About Atum
Atum is a company based in Newark (United States) founded in 2003.. Atum offers products and services including Gene Design & Synthesis Services, Antibody Services, Cell Line Development, and Protein Expression Services. Atum operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dna 2.0, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$805.16 K (USD), Grant
Feb 07, 2011
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atum
Atum offers a comprehensive portfolio of products and services, including Gene Design & Synthesis Services, Antibody Services, Cell Line Development, and Protein Expression Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers design and synthesis of genes for research applications.
Provides antibody production and engineering solutions.
Develops stable cell lines for biologics manufacturing.
Handles expression and analytics of proteins.
Unlock access to complete
Funding Insights of Atum
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $805,160
-
First Round
First Round
(14 Mar 2008)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2011 | Amount | Grant - Atum | Valuation |
investors |
|
| Mar, 2008 | Amount | Grant - Atum | Valuation |
investors |
|
| Mar, 2008 | Amount | Grant - Atum | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atum
Atum has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atum
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atum
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atum Comparisons
Competitors of Atum
Atum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atum
Frequently Asked Questions about Atum
When was Atum founded?
Atum was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Where is Atum located?
Atum is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
What does Atum do?
Atum is a synthetic biology company specializing in molecular biology and protein engineering. The company has a range of specialized products including the Electra Vector system (a single-tube 5-minute cloning platform), bacterial, mammalian and yeast protein expression vectors and expression strains of Pichia pastoris, ProteinPaintbox range of synthetic fluorescent proteins (non-Aequorea fluorescent proteins) and chromogenic proteins, CRISPRCas9 services that include the companys All-in-One NickaseNinja vector constructs for expression of dual gRNAs. The companys custom synthetic biology services include genome engineering, gene synthesis, protein engineering, and their proprietary codon optimization system for gene synthesis, called GeneGPS. Atum has also developed a protein engineering platform based on machine learning and Design of Experiment (DoE) called ProteinGPS. The started off as DNA2.0, but changed its name to Atum in December 2016. They offer their services for cell line development, protein expression (lab and large scale), gene synthesis and protein engineering.
Who are the top competitors of Atum?
Atum's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
What products or services does Atum offer?
Atum offers Gene Design & Synthesis Services, Antibody Services, Cell Line Development, and Protein Expression Services.
Who are Atum's investors?
Atum has 1 investor. Key investors include National Science Foundation.